glp-1 thibodaux Medicare's new demonstration program starts today! Learn more about it at the link in our bio! #medicare #retirement #glp1 #weightloss #turning65 NEW: Medicare GLP-1 Bridge Program

Exenatide, lixisenaide, and efpeglenide are based on the sequence of exendin-4

Foundayo isn't approved as a treatment for diabetes itself

Any unexplained weight loss beyond what is expected from the medication's therapeutic effect, or symptoms suggesting malabsorption such as pale, floating, foul-smelling stools, require investigation to exclude pancreatic or other gastrointestinal pathology

MC4R activation suppresses appetite (the mechanism behind setmelanotide, an FDA-approved MC4R agonist for obesity), but also triggers nausea, facial flushing, and spontaneous erections in males at doses above 0.5mg in nave users

PMID: 38 MaLChenCZhaoCLiTMaLJiangJet al